Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2015

Oct 7, 2015

5262_dirs_2015-10-07_7a0dd507-81af-48a7-9792-a66541dddd25.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5396B

GlaxoSmithKline PLC

07 October 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 6 October 2015, of changes in the interests of the following Persons Discharging Managerial Responsibilities ('PDMR'), following increases in their notional interests in Ordinary Shares, at a price of 1282.75 pence per Share, on the re-investment of dividends paid on Ordinary Shares held in the GlaxoSmithKline Deferred Investment Award Programme.

Director/PDMR Ordinary Shares
Mr R G Connor 438.686
Mr S A Hussain 548.357
Mr D S Redfern 438.686
Ms C Thomas 438.686
Dr P J T Vallance 548.357
Ms E Walmsley 776.811
Mrs V A Whyte 62.334

V A Whyte

Company Secretary

7 October 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSFDLFBEBFLFBE